Diabetes

A session hosted by the American Journal of Managed Care brought together an array of groups involved in managing and treating diabetes.

A recently released review finds copious evidence that higher rates of medication adherence lead to improved health outcomes and reduced overall health care costs.

As the emphasis in health care shifts from treatment to prevention, pharmacists are perfectly positioned to help patients lead healthier lives and avoid costly chronic conditions.

A study suggests that serum glucose levels that are elevated but not high enough to diagnose diabetes may indicate an elevated risk for Alzheimer's disease.

A study finds that use of sulfonylureas in the period leading up to an acute coronary syndrome is not associated with increased risk of death or heart failure.

Use of several statins appears to be associated with an increased risk of developing diabetes, and researchers advise that this risk be balanced against the drugs' cardiovascular benefits.

Ocular bleeding may be a concern for anticoagulated patients with certain risk factors and comorbidities.

A diabetes care team that included a clinical pharmacist led to major improvements in glycemic control, LDL cholesterol levels, blood pressure, and long-term cardiovascular risk.

New guidelines from the American Association of Clinical Endocrinologists cover therapy with all approved classes of diabetes drugs as well as obesity, prediabetes, and cardiovascular risk factor management.

An appeals court rules on the case of a patient who received medication meant for someone with a similar name.

Avoiding unnecessary utilization of hospitals, improving quality of care, and establishing continuous chronic disease management.

Acute coronary syndrome patients often have complex medication regimens, which means that pharmacists play an important role in condition management and patient counseling.

More than half of diabetes patients who experienced aspirin resistance with once-daily dosing overcame it when aspirin was administered in 2 daily doses.

A highly anticipated study found that a combination of niacin and the anti-flushing agent laropiprant offers no benefit to patients with vascular disease and may actually harm patients.

In some circumstances, antihypertensives can play a role in treatment even when a patient's blood pressure readings are normal.

Patients may have questions about their uncomfortable leg sensations.

Patients may have questions about their uncomfortable leg sensations.

Almost half of study participants with diabetes had osteoarthritis compared with 26% of participants without diabetes.

A new wave of mobile applications encourages disease management on the go.